Posterior Reversible Encephalopathy Syndrome (PRES) and Drug-Induced Hypersensitivity Syndrome (DIHS) following Immunotherapy and BRAF/MEK Inhibition with Continued Response in Metastatic Melanoma

Background. The role of immunotherapy continues to evolve across both solid and hematologic malignancies. However, while use of immunotherapy has increased via the advent of checkpoint inhibition, chimeric antigen receptors, and vaccines against malignant cells, there remains uncertainty regarding t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabile, J. M., Grider, D. J., Prickett, K. A., Li, H., Mallidi, P. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154311/
https://www.ncbi.nlm.nih.gov/pubmed/34113469
http://dx.doi.org/10.1155/2021/8845063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154311/
https://www.ncbi.nlm.nih.gov/pubmed/34113469
http://dx.doi.org/10.1155/2021/8845063

Ejemplares similares